Senior insider sale
Chief Medical Officer at AGIOS PHARMACEUTICALS, INC. — senior position signals high conviction
$1.06M
34.01K shares
What this filing means
GHEUENS SARAH plans to sell 34.01K shares of AGIOS PHARMACEUTICALS, INC. valued at approximately $1.06M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/4/2026ACC: 0001950047-26-007592
Officer· Chief Medical Officer
Since Sep 2021
34.01K
Shares to sell
$1.06M
Approx. market value
30K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months2
Restricted Stock
Not Applicable
12/2/2020
14.17KPerformance Shares
Not Applicable
4/14/2020
15.83KTotal acquired30K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/2/2020 | Restricted Stock Not Applicable | 14.17K | — |
4/14/2020 | Performance Shares Not Applicable | 15.83K | — |
| Total | 30K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
4.01K
Market value
$150.5K
7/1/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
30K
Market value
$914.3K
8/4/2026
Total
Units
34.01K
Value
$1.06M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/1/2026 | 4.01K | $150.5K | — | Completed |
| Planned — Approximate Date | ||||
8/4/2026 | 30K | $914.3K | NASDAQ | Planned |
| Total | 34.01K | $1.06M | ||